Business Description
Ulisse Biomed SpA
ISIN : IT0005451213
Compare
Compare
Traded in other countries / regions
UBM.Italy8XX.Germany IPO Date
2021-08-09Description
Ulisse Biomed SpA is a healthcare biotech company. It operates in diagnostics, theranostics and therapeutics with the mission to develop innovative solutions in the fields.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.61 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.23 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 2.05 | |||||
Beneish M-Score | 4.22 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.94 | |||||
9-Day RSI | 49.85 | |||||
14-Day RSI | 49.5 | |||||
6-1 Month Momentum % | -35.97 | |||||
12-1 Month Momentum % | -45.51 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.79 | |||||
Quick Ratio | 1.3 | |||||
Cash Ratio | 0.69 | |||||
Days Inventory | 246.57 | |||||
Days Sales Outstanding | 1051.69 | |||||
Days Payable | 238.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -1268.64 | |||||
Operating Margin % | -4052.54 | |||||
Net Margin % | -4065.25 | |||||
FCF Margin % | -755.08 | |||||
ROE % | -29.61 | |||||
ROA % | -25.39 | |||||
ROIC % | -33.02 | |||||
ROC (Joel Greenblatt) % | -312.75 | |||||
ROCE % | -28.95 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 86.67 | |||||
PB Ratio | 0.82 | |||||
Price-to-Tangible-Book | 4.43 | |||||
EV-to-EBIT | -4.17 | |||||
EV-to-Forward-EBIT | -6.85 | |||||
EV-to-EBITDA | -9.35 | |||||
EV-to-Forward-EBITDA | -77.75 | |||||
EV-to-Revenue | 170 | |||||
EV-to-Forward-Revenue | 9.13 | |||||
EV-to-FCF | -22.88 | |||||
Price-to-Net-Current-Asset-Value | 8.12 | |||||
Earnings Yield (Greenblatt) % | -23.91 | |||||
FCF Yield % | -3.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ulisse Biomed SpA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.118 | ||
EPS (TTM) (€) | -0.293 | ||
Beta | 0 | ||
Volatility % | 24.77 | ||
14-Day RSI | 49.5 | ||
14-Day ATR (€) | 0.029346 | ||
20-Day SMA (€) | 0.96105 | ||
12-1 Month Momentum % | -45.51 | ||
52-Week Range (€) | 0.882 - 1.865 | ||
Shares Outstanding (Mil) | 21.81 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ulisse Biomed SpA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ulisse Biomed SpA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ulisse Biomed SpA Frequently Asked Questions
What is Ulisse Biomed SpA(STU:8XX)'s stock price today?
The current price of STU:8XX is €0.97. The 52 week high of STU:8XX is €1.87 and 52 week low is €0.88.
When is next earnings date of Ulisse Biomed SpA(STU:8XX)?
The next earnings date of Ulisse Biomed SpA(STU:8XX) is .
Does Ulisse Biomed SpA(STU:8XX) pay dividends? If so, how much?
Ulisse Biomed SpA(STU:8XX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |